Algernon Pharmaceuticals Inc logo

Algernon Pharmaceuticals Inc

C$ 2.47 (-3.14%) Nov 25
P/E:
At Loss
P/B:
0.74
Market Cap:
C$ 5.82M ($ 4.35M)
Enterprise V:
C$ 4.95M ($ 3.69M)
Volume:
4.06K
Avg Vol (2M):
4.71K
Also Trade In:
Volume:
4.06K
Market Cap C$:
5.82M
Market Cap $:
4.35M
PE Ratio:
At Loss
Avg Vol (2-Month):
4.71K
Enterprise Value C$:
4.95M
Enterprise Value $:
3.69M
PB Ratio:
0.74
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is highly capital efficient and strives to deliver maximum shareholder value. Algernon's unique approach to drug discovery is based on the concept of drug repurposing.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.81
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 15.13
9-Day RSI 28.66
14-Day RSI 34.1
6-1 Month Momentum % -50.7
12-1 Month Momentum % -55.04

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.16
Quick Ratio 1.16
Cash Ratio 0.65

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -79.5
Name Current Vs Industry Vs History
ROE % -52.78
ROA % -45.34
ROIC % -75.39
ROCE % -56.75

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$)
EPS (TTM) (C$) -2.41
Beta -1.31
Volatility % 134.23
14-Day RSI 34.1
14-Day ATR (C$) 0.223293
20-Day SMA (C$) 2.799
12-1 Month Momentum % -55.04
52-Week Range (C$) 2.15 - 11.9
Shares Outstanding (Mil) 2.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Algernon Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Algernon Pharmaceuticals Inc Analysis

Share your research